NFKB1 and amyotrophic lateral sclerosis: All four of the ALS-FTLD mutants failed to activate NF-κB activity, relative to wild-type SQSTM1/p62, whereas the E396X positive control produced strong activation as previously reported (Goode et al., 2014).